23andMe Jumps as CEO Floats Taking DNA Tester Private (1)

April 18, 2024, 2:00 PM UTC

DNA testing firm 23andMe Holding Co.’s shares soared after Chief Executive Officer Anne Wojcicki said she’s considering taking the struggling company private, less than three years after it began selling shares.

Wojcicki told board members she is proposing to acquire the company in a potential go-private transaction, according to a filing with the Securities and Exchange Commission. The stock, which has traded below $1 a share since late last year, rose as much as 33% on Thursday, the biggest jump since August 2022, before paring some of the gain.

23andMe agreed to go public in 2021 via a ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.